NEWS ROOM
- 2024.02.26PassPort Technologies, Inc. Initiated US Phase I Clinical Trial of Zolmitriptan Transdermal Microporation System for the Treatment of Acute Migraine Press Release
- 2024.02.13Teijin and Axcelead to Determine the Name of Drug Discovery Research JV Press Release
- 2023.12.18Axcelead’s Presentation Date and Time at the 42nd Annual JP Morgan Healthcare Conference Topics
- 2023.12.18PassPort Technologies Commences Collaborative Research with Arcturus Therapeutics Topics
- 2023.12.06Axcelead to Present at the 42nd Annual J.P. Morgan Healthcare Conference Topics